Adicet Bio stockholders approve doubling authorized shares to 300M and 5M share plan increase

Adicet Bio, Inc.

Authorized common shares increased from 150M to 300M via charter amendment; filed June 6.
2018 Stock Plan increased by 5M shares to 16.6M total; approved with 28.9M votes for.
Contingent option grants become effective: CEO Chen Schor receives 1.77M options; CFO Nick Harvey 375k; total 3.3M across management.
Charter amendment adopted to limit officer liability as permitted by Delaware law.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.